SGEM#235: Edoxaban for Cancer Associated VTE – Would the NEJM Lie to You?
1 ensaioEnsaios extraídos do podcast de Dr. Ken Milne
- 2018Hokusai VTE CancerAnticoagulation & AntithromboticsIn 1046 patients with cancer-associated venous thromboembolism, edoxaban was noninferior to dalteparin for recurrent VTE or major bleeding at 12 months.